Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric acidergic transmission in the central amygdala in cocaine addiction

Biological Psychiatry

Volumn 74, Issue 7, 2013, Pages 520-528

  Kallupi, Marsida ^a,c   Wee, Sunmee ^b,c   Edwards, Scott ^c   Whitfield, Timothy W ^c   Oleata, Christopher S ^c   Luu, George ^c   Schmeichel, Brooke E ^c   Koob, George F ^c   Roberto, Marisa ^c  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Addiction; anxiety; central amygdale; cocaine; GABA; kappa opioid receptor

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 AMINOBUTYRIC ACID; COCAINE; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN SLICE; CENTRAL NUCLEUS (AMYGDALA); COCAINE DEPENDENCE; COMPARATIVE STUDY; CONTROLLED STUDY; GABAERGIC TRANSMISSION; IN VITRO STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; WHOLE CELL;

ADDICTION; ANXIETY; CENTRAL AMYGDALA; COCAINE; GABA; KAPPA-OPIOID RECEPTOR;

AMYGDALA; ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; GAMMA-AMINOBUTYRIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; SELF ADMINISTRATION;

EID: 84883820194     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.04.028     Document Type: Article

References (53)

1. D.W. Self, and E.J. Nestler Molecular mechanisms of drug reinforcement and addiction Annu Rev Neurosci 18 1995 463 495
2. G.F. Koob, and M. Le Moal Drug abuse: Hedonic homeostatic dysregulation Science 278 1997 52 58
3. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology 35 2010 217 238
4. S. Edwards, and G.F. Koob Neurobiology of dysregulated motivational systems in drug addiction Future Neurol 5 2010 393 401
5. G.F. Alheid, and L. Heimer New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata Neuroscience 27 1988 1 39
6. S.H. Ahmed, P.J. Kenny, G.F. Koob, and A. Markou Neurobiological evidence for hedonic allostasis associated with escalating cocaine use Nat Neurosci 5 2002 625 626
7. F. Weiss, R. Ciccocioppo, L.H. Parsons, S. Katner, X. Liu, and E.P. Zorrilla Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors Ann N Y Acad Sci 937 2001 1 26
8. S. Pollandt, J. Liu, L. Orozco-Cabal, D.E. Grigoriadis, W.W. Vale, J.P. Gallagher, and P. Shinnick-Gallagher Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA Eur J Neurosci 24 2006 1733 1743
9. N.J. Marchant, V.S. Densmore, and P.B. Osborne Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: Evidence of two distinct endogenous opioid systems in the lateral division J Comp Neurol 504 2007 702 715
10. S. Wee, and G.F. Koob The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse Psychopharmacology (Berl) 210 2010 121 135
11. E.R. Butelman, V. Yuferov, and M.J. Kreek Kappa-opioid receptor/dynorphin system: Genetic and pharmacotherapeutic implications for addiction Trends Neurosci 35 2012 587 596
12. C. Chavkin, I.F. James, and A. Goldstein Dynorphin is a specific endogenous ligand of the kappa opioid receptor Science 215 1982 413 415
13. A. Mansour, H. Khachaturian, M.E. Lewis, H. Akil, and S.J. Watson Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain J Neurosci 7 1987 2445 2464
14. E.H. Chartoff, D. Potter, D. Damez-Werno, B.M. Cohen, and W.A. Carlezon Jr Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats Neuropsychopharmacology 33 2008 2676 2687
15. A.S. Portoghese, A.W. Lipkowski, and A.E. Takemori Bimorphinans as highly selective, potent kappa opioid receptor antagonists J Med Chem 30 1987 238 239
16. S. Wee, L. Orio, S. Ghirmai, J.R. Cashman, and G.F. Koob Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine Psychopharmacology (Berl) 205 2009 565 575
17. W.A. Carlezon Jr, J. Thome, V.G. Olson, S.B. Lane-Ladd, E.S. Brodkin, and N. Hiroi Regulation of cocaine reward by CREB Science 282 1998 2272 2275
18. G. Di Chiara, and A. Imperato Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats J Pharmacol Exp Ther 244 1988 1067 1080
19. G.O. Hjelmstad, and H.L. Fields Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell J Neurophysiol 85 2001 1153 1158
20. Kissler JL, Sirohi S, Reis DJ, Jansen HT, Quock RM, Smith DG, et al. (2013): The one-two punch of alcoholism: Role of central amygdala dynorphins/kappa-opioid receptors [published online ahead of print April 20]. Biol Psychiatry.
21. M. Roberto, S.G. Madamba, S.D. Moore, M.K. Tallent, and G.R. Siggins Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons Proc Natl Acad Sci U S A 100 2003 2053 2058
22. M. Roberto, S.G. Madamba, D.G. Stouffer, L.H. Parsons, and G.R. Siggins Increased GABA release in the central amygdala of ethanol-dependent rats J Neurosci 24 2004 10159 10166
23. M.T. Cruz, M.A. Herman, D.M. Cote, A.E. Ryabinin, and M. Roberto Ghrelin increases GABAergic transmission and interacts with ethanol actions in the rat central nucleus of the amygdala Neuropsychopharmacology 38 2013 364 375
24. N.W. Gilpin, K. Misra, M.A. Herman, M.T. Cruz, G.F. Koob, and M. Roberto Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence Biol Psychiatry 69 2011 1091 1099
25. B. Schilstrom, R. Yaka, E. Argilli, N. Suvarna, J. Schumann, and B.T. Chen Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors J Neurosci 26 2006 8549 8558
26. E. Argilli, D.R. Sibley, R.C. Malenka, P.M. England, and A. Bonci Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area J Neurosci 28 2008 9092 9100
27. S. Oleskevich, and J.T. Williams Cocaine prolongs norepinephrine synaptic potentials in rat dorsal raphe J Neurophysiol 73 1995 687 692
28. M. Roberto, M.T. Cruz, N.W. Gilpin, V. Sabino, P. Schweitzer, and M. Bajo Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence Biol Psychiatry 67 2010 831 839
29. N.B. Fredj, and J. Burrone A resting pool of vesicles is responsible for spontaneous vesicle fusion at the synapse Nat Neurosci 12 2009 751 758
30. C.R. Wasser, and E.T. Kavalali Leaky synapses: Regulation of spontaneous neurotransmission in central synapses Neuroscience 158 2009 177 188
31. M.A. Herman, M. Kallupi, G. Luu, C.S. Oleata, M. Heilig, and G.F. Koob Enhanced GABAergic transmission in the central nucleus of the amygdala of genetically selected Marchigian Sardinian rats: Alcohol and CRF effects Neuropharmacology 67 2013 337 348
32. M.R. Bruchas, and C. Chavkin Kinase cascades and ligand-directed signaling at the kappa opioid receptor Psychopharmacology (Berl) 210 2010 137 147
33. S. Edwards, D.L. Graham, R.K. Bachtell, and D.W. Self Region-specific tolerance to cocaine-regulated cAMP-dependent protein phosphorylation following chronic self-administration Eur J Neurosci 25 2007 2201 2213
34. B.B. Land, M.R. Bruchas, J.C. Lemos, M. Xu, E.J. Melief, and C. Chavkin The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system J Neurosci 28 2008 407 414
35. M.R. Bruchas, B.B. Land, J.C. Lemos, and C. Chavkin CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior PloS One 4 2009 e8528
36. M.R. Bruchas, B.B. Land, and C. Chavkin The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors Brain Res 1314 2010 44 55
37. E. Chartoff, A. Sawyer, A. Rachlin, D. Potter, A. Pliakas, and W.A. Carlezon Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats Neuropharmacology 62 2012 167 176
38. Y.L. Hurd, P. Svensson, and M. Ponten The role of dopamine, dynorphin, and CART systems in the ventral striatum and amygdala in cocaine abuse Ann N Y Acad Sci 877 1999 499 506
39. J.B. Daunais, D.C. Roberts, and J.F. McGinty Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum Neuroreport 4 1993 543 546
40. R. Spangler, E.M. Unterwald, and M.J. Kreek 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen Brain Res Mol Brain Res 19 1993 323 327
41. P. Fagergren, H.R. Smith, J.B. Daunais, M.A. Nader, L.J. Porrino, and Y.L. Hurd Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration Eur J Neurosci 17 2003 2212 2218
42. S.P. Sivam Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism J Pharmacol Exp Ther 250 1989 818 824
43. P.L. Smiley, M. Johnson, L. Bush, J.W. Gibb, and G.R. Hanson Effects of cocaine on extrapyramidal and limbic dynorphin systems J Pharmacol Exp Ther 253 1990 938 943
44. Y.L. Hurd, and M. Herkenham Molecular alterations in the neostriatum of human cocaine addicts Synapse 13 1993 357 369
45. E.M. Unterwald, J.M. Rubenfeld, and M.J. Kreek Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors Neuroreport 5 1994 1613 1616
46. T.S. Shippenberg, and A. Herz Differential effects of mu and kappa opioid systems on motivational processes NIDA Res Monogr 75 1986 563 566
47. J.P. McLaughlin, S. Li, J. Valdez, T.A. Chavkin, and C. Chavkin Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system Neuropsychopharmacology 31 2006 1241 1248
48. A.T. Knoll, and W.A. Carlezon Jr Dynorphin, stress, and depression Brain Res 1314 2010 56 73
49. T.S. Shippenberg, and W. Rea Sensitization to the behavioral effects of cocaine: Modulation by dynorphin and kappa-opioid receptor agonists Pharmacol Biochem Behav 57 1997 449 455
50. S. Schenk, B. Partridge, and T.S. Shippenberg U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking Psychopharmacology (Berl) 144 1999 339 346
51. S.H. Ahmed, and G.F. Koob Transition from moderate to excessive drug intake: Change in hedonic set point Science 282 1998 298 300
52. P.V. Piazza, V. Deroche-Gamonent, F. Rouge-Pont, and M. Le Moal Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction J Neurosci 20 2000 4226 4232
53. S. Edwards, K.N. Whisler, D.C. Fuller, P.J. Orsulak, and D.W. Self Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration Neuropsychopharmacology 32 2007 354 366